LASILIX 20 mg/2 ml, solution for injection in an ampoule 60 ampoules of 2 ml
Active ingredients: Furosemide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection60 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LASILIX 20 mg/2 ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 60 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Feb 2015
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66441419CIP75868803CIP133400958688034Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUROSÉMIDEsolution | 20 mg · une ampoule de 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.